CHINA PHARMA HOLDINGS, INC. Proceeds from Warrant Exercises
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Proceeds from Warrant Exercises of $0 for the 9-month period ending 2011-09-30, per its 10-Q/A filed 2012-03-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2012-03-14
- CHINA PHARMA HOLDINGS, INC. proceeds from warrant exercises for the quarter ending 2011-09-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. proceeds from warrant exercises for the quarter ending 2010-12-31 was $0.00.
- CHINA PHARMA HOLDINGS, INC. proceeds from warrant exercises for the quarter ending 2010-09-30 was $0.00.
- CHINA PHARMA HOLDINGS, INC. proceeds from warrant exercises for fiscal 2010 was $2.58M.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2011-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $0.00 10-Q/A · filed 2012-03-06 | ||
| 2011-06-30 | $0.00 10-Q/A · filed 2011-09-06 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-14 | $0.00 derived: sum of 2 quarters · filed 2012-03-14 | $2.58M 10-K · filed 2012-03-14 | |
| 2010-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-03-06 | $2.58M 10-Q/A · filed 2012-03-06 | ||
| 2010-06-30 | $2.58M 10-Q/A · filed 2011-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |